Latest Industry Insights

HPLC system manufacturers have been striving to improve usability, accessibility and help users improve their experimental outcomes. And what better way to do that than to involve the users themselves in that development process.

Technology Networks had the pleasure of speaking with Chris Wightman, founder and chief executive officer at VM Agritech, to learn more about fungicide resistance and the development of novel fungicides designed to tackle this issue.

Explore the importance of location-specific expertise in global research collaborations and how to overcome challenges faced by in-house R&D teams when engaging with global partners.

We spoke to Prof. Oscar Ces, head of the Department of Chemistry at Imperial College London (ICL), to find out about the evolution of ICL’s White City Campus, the Agilent Measurement Suite and what it means for scientists across the board.

Technology Networks spoke with Ken Suzuki and Jennifer Gushue to learn more about how Agilent is addressing customer needs with novel “intelligence” features and the company’s efforts to ensure the sustainability and longevity of its products

Researchers have made significant strides toward developing improved battery chemistries, but scaling up production is challenging. To find out more, we spoke to Zhao Liu, senior market development manager at Thermo Fisher Scientific.

Technology Networks recently spoke with Tom Schafer, Vice President at Koch Modular Process Systems, to learn more about the pongamia tree, how its bitter taste can be processed out and the potential uses for pongamia oil.

At ASMS 2023, Technology Networks spoke with Dr. Chris Lock, vice president of global research and development at SCIEX, to discuss the newly launched Intabio ZT system.

Renewed efforts to tap cyanobacteria, algae and plants in arenas typically dominated by heterotrophic systems are already beginning to yield fruit. In this article, we explore the inherent value of photosynthetic biotechnologies and their challenges.

Shark-derived squalene is a common adjuvant product found in several approved vaccines. As calls for a sustainable source of squalene increase, researchers are exploring how yeast can be used to produce squalene analogues.